Main Menu
Menu

Fact Checks

Publish Date
BlogFact Checks
Fact Check: Debunking the Patent “Evergreening” Myth

On April 16, the R Street Institute hosted a congressional briefing entitled “The Hidden Tax: How Bad Patents Drive Up Drug Prices...

BlogFact Checks
Fact Check: The ETHIC Act Targets a Problem That Doesn’t Exist

Congress is considering a bill, the Eliminating Thickets to Increase Competition (ETHIC) Act, that would undermine innovation by preventing patent owners from...

BlogFact Checks
Fact Check: Limiting Injunctive Relief Harms, Not Helps, Inventors

Among the most consequential foreign policy developments is the European Union’s (EU’s) consideration of policies that could limit access to injunctive relief....

BlogFact Checks
Fact Check: The NO FAKES Act Won’t Stifle Innovation — It Will Protect It

The rapid advancement of artificial intelligence has given creators and inventors new technological tools to enhance their work — but it has...

BlogFact Checks
Fact Check: Debunking The Myth of “Evergreening” and “Patent Thicketing”

Former Federal Trade Commission Chair Lina Khan recently appeared on The Weekly Show with Jon Stewart, where their discussion revived familiar tropes...

BlogFact Checks
Fact Check: What Critics Get Wrong About the Patent Eligibility Restoration Act

A coalition of anti-patent groups — including the R Street Institute, the Electronic Frontier Foundation, Public Knowledge, and others — recently sent...

BlogFact Checks
Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.

In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs....

BlogFact Checks
Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”

Several academic authors recently published an article in Health Affairs Forefront advising policymakers in Congress and at the USPTO on the best...

BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology
Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences
BlogFact Checks
Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry

Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a...

Blog:

Blog, Fact Checks:

Fact Check: The Patent Eligibility Restoration Act Does Not Allow Patenting of Naturally-Occurring Genes,

08/23/2023
Blog:

Blog, Fact Checks:

Fact Check: The ITC’s Import Process and Bans Help Protect U.S. Innovators,

07/10/2023
Blog:

Blog, Fact Checks:

The Bayh-Dole Act Does Not Impede Knowledge Sharing,

06/16/2023
Blog:

Blog, Fact Checks:

Fact Check: Senator Sanders’ Misguided Hearing,

05/23/2023
Fact Checks:

Blog, Fact Checks:

An Expanded TRIPS Waiver is Unnecessary,

05/03/2023
Blog:

Blog, Fact Checks:

Fact Check: There Is No Patent Quality Crisis,

04/18/2023
Blog:

Blog, Fact Checks:

Fact Check: Proposed FTC Rule to Ban Non-Competes Will Hamper Innovation,

03/03/2023
Scroll to Top